ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
7 hedge funds and large institutions have $385K invested in Avenue Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$280K | |
| 2 | +$82.2K | |
| 3 | +$3.55K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.71K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$8 |
Top Sellers
| 1 | -$286K | |
| 2 | -$157K | |
| 3 | -$27.4K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$122 |
| 5 |
JPMorgan Chase & Co
New York
|
-$3 |